Aura Biosciences, Inc.AURANASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank60
3Y CAGR-52.3%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-52.3%/yr
Annual compound
Percentile
P60
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | 15.46% |
| 2023 | 9.43% |
| 2022 | 78.98% |
| 2021 | 142.29% |
| 2020 | -7.94% |
| 2019 | 0.00% |